NASDAQ:PLXS - Plexus Stock Price, Forecast & News

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings results on Wednesday, January, 22nd. The technology company reported $1.00 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.07. The technology company had revenue of $852.40 million for the quarter, compared to analysts' expectations of $803.38 million. Plexus had a return on equity of 12.26% and a net margin of 3.61%. The firm's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. View Plexus' Earnings History.

Plexus is scheduled to release their next quarterly earnings announcement on Wednesday, April 15th 2020. View Earnings Estimates for Plexus.

Plexus issued an update on its second quarter earnings guidance on Wednesday, January, 22nd. The company provided earnings per share (EPS) guidance of $0.80-0.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.96. The company issued revenue guidance of $790-830 million, compared to the consensus revenue estimate of $821.36 million.

2 brokers have issued 12-month target prices for Plexus' shares. Their forecasts range from $83.00 to $88.00. On average, they expect Plexus' share price to reach $85.50 in the next twelve months. This suggests a possible upside of 17.9% from the stock's current price. View Analyst Price Targets for Plexus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Plexus.

News articles about PLXS stock have been trending somewhat positive on Sunday, according to InfoTrie. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Plexus earned a coverage optimism score of 1.6 on InfoTrie's scale. They also gave media coverage about the technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Plexus.

Plexus saw a decline in short interest in January. As of January 31st, there was short interest totalling 921,600 shares, a decline of 7.8% from the January 15th total of 1,000,000 shares. Based on an average trading volume of 202,600 shares, the days-to-cover ratio is presently 4.5 days. Currently, 3.2% of the company's shares are sold short. View Plexus' Current Options Chain.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Jabil (JBL), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), KEMET (KEM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Key Tronic (KTCC) and Neonode (NEON).

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Cisco Systems (CSCO), Berry Global Group (BERY), Intel (INTC), QUALCOMM (QCOM), salesforce.com (CRM), Pfizer (PFE), Twitter (TWTR) and First Solar (FSLR).

Plexus' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (4.59%), State Street Corp (3.05%), Massachusetts Financial Services Co. MA (2.11%), Victory Capital Management Inc. (2.10%), Victory Capital Management Inc. (2.08%) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.84%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Institutional Ownership Trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Thrivent Financial for Lutherans, Massachusetts Financial Services Co. MA, Hotchkis & Wiley Capital Management LLC, State Street Corp, Tocqueville Asset Management L.P., Arizona State Retirement System and Public Sector Pension Investment Board. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Insider Buying and Selling for Plexus.

PLXS stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Man Group plc, Renaissance Technologies LLC, Mackay Shields LLC, Great West Life Assurance Co. Can and Acadian Asset Management LLC. View Insider Buying and Selling for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $72.50.

Plexus has a market capitalization of $2.13 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.View Additional Information About Plexus.

The official website for Plexus is http://www.plexus.com/.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]